nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CYP2C9—brain cancer	0.629	1	CbGaD
Hexobarbital—CYP1A2—Carmustine—brain cancer	0.0607	0.248	CbGbCtD
Hexobarbital—CYP3A4—Temozolomide—brain cancer	0.0459	0.188	CbGbCtD
Hexobarbital—PTGS1—Etoposide—brain cancer	0.0403	0.165	CbGbCtD
Hexobarbital—CYP3A4—Lomustine—brain cancer	0.039	0.16	CbGbCtD
Hexobarbital—CYP2E1—Etoposide—brain cancer	0.0311	0.127	CbGbCtD
Hexobarbital—CYP1A2—Etoposide—brain cancer	0.018	0.0736	CbGbCtD
Hexobarbital—CYP3A4—Etoposide—brain cancer	0.00942	0.0386	CbGbCtD
Hexobarbital—GRIK2—cerebellar cortex—brain cancer	0.00841	0.0746	CbGeAlD
Hexobarbital—CHRNA4—cochlea—brain cancer	0.00616	0.0547	CbGeAlD
Hexobarbital—GRIK2—telencephalic ventricle—brain cancer	0.00489	0.0434	CbGeAlD
Hexobarbital—CHRNA4—telencephalic ventricle—brain cancer	0.00393	0.0349	CbGeAlD
Hexobarbital—GRIA2—ganglion—brain cancer	0.00337	0.0299	CbGeAlD
Hexobarbital—GRIK2—ganglion—brain cancer	0.00304	0.027	CbGeAlD
Hexobarbital—GRIA2—hindbrain—brain cancer	0.00256	0.0227	CbGeAlD
Hexobarbital—CHRNA7—ganglion—brain cancer	0.00248	0.022	CbGeAlD
Hexobarbital—GABRA6—hindbrain—brain cancer	0.00247	0.0219	CbGeAlD
Hexobarbital—CHRNA4—ganglion—brain cancer	0.00245	0.0217	CbGeAlD
Hexobarbital—GRIK2—hindbrain—brain cancer	0.00231	0.0205	CbGeAlD
Hexobarbital—GABRA2—ganglion—brain cancer	0.00219	0.0194	CbGeAlD
Hexobarbital—CHRNA4—hindbrain—brain cancer	0.00186	0.0165	CbGeAlD
Hexobarbital—GABRA2—hindbrain—brain cancer	0.00166	0.0147	CbGeAlD
Hexobarbital—GABRA1—hindbrain—brain cancer	0.0016	0.0142	CbGeAlD
Hexobarbital—GRIA2—brainstem—brain cancer	0.00146	0.013	CbGeAlD
Hexobarbital—GABRA6—brainstem—brain cancer	0.00142	0.0126	CbGeAlD
Hexobarbital—GRIK2—brainstem—brain cancer	0.00132	0.0117	CbGeAlD
Hexobarbital—GRIA2—telencephalon—brain cancer	0.0013	0.0115	CbGeAlD
Hexobarbital—GABRA6—telencephalon—brain cancer	0.00126	0.0111	CbGeAlD
Hexobarbital—GABRA5—telencephalon—brain cancer	0.00122	0.0108	CbGeAlD
Hexobarbital—CHRFAM7A—telencephalon—brain cancer	0.00118	0.0105	CbGeAlD
Hexobarbital—GRIK2—telencephalon—brain cancer	0.00117	0.0104	CbGeAlD
Hexobarbital—PTGS1—ganglion—brain cancer	0.00113	0.01	CbGeAlD
Hexobarbital—GABRA4—telencephalon—brain cancer	0.00111	0.00981	CbGeAlD
Hexobarbital—CHRNA4—brainstem—brain cancer	0.00106	0.00944	CbGeAlD
Hexobarbital—PTGS1—endothelium—brain cancer	0.000973	0.00863	CbGeAlD
Hexobarbital—CHRNA7—telencephalon—brain cancer	0.000957	0.00849	CbGeAlD
Hexobarbital—GABRA2—brainstem—brain cancer	0.000952	0.00845	CbGeAlD
Hexobarbital—CHRNA4—telencephalon—brain cancer	0.000944	0.00838	CbGeAlD
Hexobarbital—GRIA2—midbrain—brain cancer	0.000933	0.00829	CbGeAlD
Hexobarbital—GRIK2—medulla oblongata—brain cancer	0.000923	0.00819	CbGeAlD
Hexobarbital—GABRA1—brainstem—brain cancer	0.00092	0.00816	CbGeAlD
Hexobarbital—GRIA2—spinal cord—brain cancer	0.000911	0.00808	CbGeAlD
Hexobarbital—GABRA4—pituitary gland—brain cancer	0.0009	0.00799	CbGeAlD
Hexobarbital—PTGS1—blood vessel—brain cancer	0.000897	0.00796	CbGeAlD
Hexobarbital—GABRA2—telencephalon—brain cancer	0.000845	0.0075	CbGeAlD
Hexobarbital—GRIK2—midbrain—brain cancer	0.000843	0.00749	CbGeAlD
Hexobarbital—GRIK2—spinal cord—brain cancer	0.000823	0.0073	CbGeAlD
Hexobarbital—GRIA2—endocrine gland—brain cancer	0.00082	0.00728	CbGeAlD
Hexobarbital—GABRA1—telencephalon—brain cancer	0.000816	0.00725	CbGeAlD
Hexobarbital—GRIA2—head—brain cancer	0.000809	0.00718	CbGeAlD
Hexobarbital—GABRA6—head—brain cancer	0.000782	0.00694	CbGeAlD
Hexobarbital—GABRA5—head—brain cancer	0.000759	0.00673	CbGeAlD
Hexobarbital—CHRFAM7A—endocrine gland—brain cancer	0.000747	0.00663	CbGeAlD
Hexobarbital—GRIK2—endocrine gland—brain cancer	0.000741	0.00657	CbGeAlD
Hexobarbital—GRIA2—central nervous system—brain cancer	0.000739	0.00656	CbGeAlD
Hexobarbital—CHRFAM7A—head—brain cancer	0.000738	0.00655	CbGeAlD
Hexobarbital—GRIK2—head—brain cancer	0.000731	0.00649	CbGeAlD
Hexobarbital—GRIA2—cerebellum—brain cancer	0.000722	0.00641	CbGeAlD
Hexobarbital—GABRA3—endocrine gland—brain cancer	0.000715	0.00635	CbGeAlD
Hexobarbital—GABRA6—central nervous system—brain cancer	0.000714	0.00634	CbGeAlD
Hexobarbital—GABRA3—head—brain cancer	0.000706	0.00627	CbGeAlD
Hexobarbital—GABRA6—cerebellum—brain cancer	0.000698	0.00619	CbGeAlD
Hexobarbital—GABRA5—central nervous system—brain cancer	0.000692	0.00615	CbGeAlD
Hexobarbital—GABRA4—head—brain cancer	0.000688	0.00611	CbGeAlD
Hexobarbital—CHRNA4—midbrain—brain cancer	0.000678	0.00602	CbGeAlD
Hexobarbital—CHRFAM7A—central nervous system—brain cancer	0.000673	0.00598	CbGeAlD
Hexobarbital—GRIK2—central nervous system—brain cancer	0.000667	0.00592	CbGeAlD
Hexobarbital—CHRNA4—spinal cord—brain cancer	0.000661	0.00587	CbGeAlD
Hexobarbital—GRIK2—cerebellum—brain cancer	0.000652	0.00579	CbGeAlD
Hexobarbital—GABRA3—central nervous system—brain cancer	0.000645	0.00572	CbGeAlD
Hexobarbital—GABRA1—medulla oblongata—brain cancer	0.000641	0.00569	CbGeAlD
Hexobarbital—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000635	0.0446	CbGpPWpGaD
Hexobarbital—GABRA4—central nervous system—brain cancer	0.000628	0.00558	CbGeAlD
Hexobarbital—GABRA4—cerebellum—brain cancer	0.000614	0.00545	CbGeAlD
Hexobarbital—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.000608	0.0427	CbGpPWpGaD
Hexobarbital—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000605	0.0425	CbGpPWpGaD
Hexobarbital—CHRNA7—endocrine gland—brain cancer	0.000603	0.00536	CbGeAlD
Hexobarbital—CHRNA7—head—brain cancer	0.000596	0.00529	CbGeAlD
Hexobarbital—CHRNA4—endocrine gland—brain cancer	0.000595	0.00528	CbGeAlD
Hexobarbital—CHRNA4—head—brain cancer	0.000588	0.00522	CbGeAlD
Hexobarbital—GRIA2—brain—brain cancer	0.000587	0.00521	CbGeAlD
Hexobarbital—GABRA1—midbrain—brain cancer	0.000586	0.0052	CbGeAlD
Hexobarbital—GABRA1—spinal cord—brain cancer	0.000572	0.00508	CbGeAlD
Hexobarbital—GABRA6—brain—brain cancer	0.000567	0.00503	CbGeAlD
Hexobarbital—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000551	0.0387	CbGpPWpGaD
Hexobarbital—GABRA5—brain—brain cancer	0.00055	0.00488	CbGeAlD
Hexobarbital—CHRNA7—central nervous system—brain cancer	0.000544	0.00483	CbGeAlD
Hexobarbital—CHRNA4—central nervous system—brain cancer	0.000536	0.00476	CbGeAlD
Hexobarbital—CHRFAM7A—brain—brain cancer	0.000534	0.00474	CbGeAlD
Hexobarbital—GRIK2—brain—brain cancer	0.00053	0.0047	CbGeAlD
Hexobarbital—GABRA2—head—brain cancer	0.000526	0.00467	CbGeAlD
Hexobarbital—CHRNA4—cerebellum—brain cancer	0.000524	0.00465	CbGeAlD
Hexobarbital—GABRA3—brain—brain cancer	0.000512	0.00454	CbGeAlD
Hexobarbital—GABRA1—head—brain cancer	0.000508	0.00451	CbGeAlD
Hexobarbital—GABRA4—brain—brain cancer	0.000499	0.00443	CbGeAlD
Hexobarbital—GABRA2—central nervous system—brain cancer	0.00048	0.00426	CbGeAlD
Hexobarbital—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000472	0.0331	CbGpPWpGaD
Hexobarbital—GABRA2—cerebellum—brain cancer	0.000469	0.00417	CbGeAlD
Hexobarbital—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000469	0.0329	CbGpPWpGaD
Hexobarbital—GABRA1—central nervous system—brain cancer	0.000464	0.00412	CbGeAlD
Hexobarbital—GABRA1—cerebellum—brain cancer	0.000454	0.00403	CbGeAlD
Hexobarbital—CYP2E1—telencephalon—brain cancer	0.000452	0.00401	CbGeAlD
Hexobarbital—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00044	0.0309	CbGpPWpGaD
Hexobarbital—PTGS1—telencephalon—brain cancer	0.000435	0.00386	CbGeAlD
Hexobarbital—CHRNA7—brain—brain cancer	0.000432	0.00383	CbGeAlD
Hexobarbital—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000429	0.0301	CbGpPWpGaD
Hexobarbital—CHRNA4—brain—brain cancer	0.000426	0.00378	CbGeAlD
Hexobarbital—CYP2C19—endocrine gland—brain cancer	0.000388	0.00344	CbGeAlD
Hexobarbital—GABRA2—brain—brain cancer	0.000381	0.00338	CbGeAlD
Hexobarbital—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000377	0.0265	CbGpPWpGaD
Hexobarbital—GABRA1—brain—brain cancer	0.000368	0.00327	CbGeAlD
Hexobarbital—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000363	0.0254	CbGpPWpGaD
Hexobarbital—CYP2E1—medulla oblongata—brain cancer	0.000355	0.00315	CbGeAlD
Hexobarbital—PTGS1—pituitary gland—brain cancer	0.000354	0.00314	CbGeAlD
Hexobarbital—CYP1A2—endocrine gland—brain cancer	0.000317	0.00281	CbGeAlD
Hexobarbital—CYP2E1—spinal cord—brain cancer	0.000316	0.00281	CbGeAlD
Hexobarbital—PTGS1—spinal cord—brain cancer	0.000305	0.00271	CbGeAlD
Hexobarbital—CYP2C9—endocrine gland—brain cancer	0.000301	0.00267	CbGeAlD
Hexobarbital—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000291	0.0204	CbGpPWpGaD
Hexobarbital—CYP2E1—endocrine gland—brain cancer	0.000285	0.00253	CbGeAlD
Hexobarbital—CYP2E1—head—brain cancer	0.000281	0.0025	CbGeAlD
Hexobarbital—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00028	0.0196	CbGpPWpGaD
Hexobarbital—PTGS1—endocrine gland—brain cancer	0.000274	0.00244	CbGeAlD
Hexobarbital—PTGS1—head—brain cancer	0.000271	0.00241	CbGeAlD
Hexobarbital—CYP2E1—central nervous system—brain cancer	0.000257	0.00228	CbGeAlD
Hexobarbital—GABRA6—Orphan transporters—S100A10—brain cancer	0.000253	0.0178	CbGpPWpGaD
Hexobarbital—CYP2E1—cerebellum—brain cancer	0.000251	0.00223	CbGeAlD
Hexobarbital—GABRA4—Orphan transporters—S100A10—brain cancer	0.00025	0.0175	CbGpPWpGaD
Hexobarbital—PTGS1—central nervous system—brain cancer	0.000247	0.0022	CbGeAlD
Hexobarbital—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000247	0.0173	CbGpPWpGaD
Hexobarbital—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000242	0.017	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—HES5—brain cancer	0.000236	0.0165	CbGpPWpGaD
Hexobarbital—CYP3A4—endocrine gland—brain cancer	0.000229	0.00203	CbGeAlD
Hexobarbital—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000227	0.0159	CbGpPWpGaD
Hexobarbital—GABRA5—Orphan transporters—S100A10—brain cancer	0.000222	0.0156	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—NTRK3—brain cancer	0.000218	0.0153	CbGpPWpGaD
Hexobarbital—GABRA3—Orphan transporters—S100A10—brain cancer	0.000218	0.0153	CbGpPWpGaD
Hexobarbital—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000218	0.0153	CbGpPWpGaD
Hexobarbital—GABRA2—Orphan transporters—S100A10—brain cancer	0.000214	0.015	CbGpPWpGaD
Hexobarbital—CYP3A4—central nervous system—brain cancer	0.000207	0.00183	CbGeAlD
Hexobarbital—CYP2E1—brain—brain cancer	0.000204	0.00181	CbGeAlD
Hexobarbital—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0002	0.014	CbGpPWpGaD
Hexobarbital—PTGS1—brain—brain cancer	0.000196	0.00174	CbGeAlD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000192	0.0135	CbGpPWpGaD
Hexobarbital—GABRA1—Orphan transporters—S100A10—brain cancer	0.000183	0.0128	CbGpPWpGaD
Hexobarbital—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000175	0.0123	CbGpPWpGaD
Hexobarbital—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00017	0.0119	CbGpPWpGaD
Hexobarbital—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000168	0.0118	CbGpPWpGaD
Hexobarbital—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000157	0.011	CbGpPWpGaD
Hexobarbital—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000154	0.0108	CbGpPWpGaD
Hexobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000148	0.0104	CbGpPWpGaD
Hexobarbital—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00014	0.00981	CbGpPWpGaD
Hexobarbital—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000127	0.00891	CbGpPWpGaD
Hexobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000121	0.00848	CbGpPWpGaD
Hexobarbital—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00012	0.00843	CbGpPWpGaD
Hexobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000119	0.00837	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000119	0.00835	CbGpPWpGaD
Hexobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000114	0.00803	CbGpPWpGaD
Hexobarbital—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000109	0.00764	CbGpPWpGaD
Hexobarbital—GRIA2—N-cadherin signaling events—CTNNB1—brain cancer	0.000106	0.00745	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—ESR2—brain cancer	0.0001	0.00704	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.79e-05	0.00687	CbGpPWpGaD
Hexobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	9.41e-05	0.00661	CbGpPWpGaD
Hexobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	9.29e-05	0.00652	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—CYP2C9—brain cancer	9.02e-05	0.00633	CbGpPWpGaD
Hexobarbital—GABRA6—Ion channel transport—TRPC6—brain cancer	8.2e-05	0.00575	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—ESR2—brain cancer	8.17e-05	0.00574	CbGpPWpGaD
Hexobarbital—GABRA4—Ion channel transport—TRPC6—brain cancer	8.09e-05	0.00568	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—HES1—brain cancer	7.79e-05	0.00547	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.63e-05	0.00535	CbGpPWpGaD
Hexobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.26e-05	0.0051	CbGpPWpGaD
Hexobarbital—GABRA5—Ion channel transport—TRPC6—brain cancer	7.19e-05	0.00505	CbGpPWpGaD
Hexobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.17e-05	0.00503	CbGpPWpGaD
Hexobarbital—GABRA3—Ion channel transport—TRPC6—brain cancer	7.06e-05	0.00496	CbGpPWpGaD
Hexobarbital—GABRA2—Ion channel transport—TRPC6—brain cancer	6.94e-05	0.00487	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—CYP2C9—brain cancer	6.74e-05	0.00473	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	6.65e-05	0.00467	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—SPP1—brain cancer	6.45e-05	0.00453	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—HES1—brain cancer	6.35e-05	0.00446	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	6.18e-05	0.00434	CbGpPWpGaD
Hexobarbital—CYP3A4—Irinotecan Pathway—APC—brain cancer	6.17e-05	0.00433	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	6.1e-05	0.00428	CbGpPWpGaD
Hexobarbital—GABRA1—Ion channel transport—TRPC6—brain cancer	5.92e-05	0.00415	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.89e-05	0.00413	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—IRS2—brain cancer	5.83e-05	0.00409	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	5.53e-05	0.00388	CbGpPWpGaD
Hexobarbital—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	5.47e-05	0.00384	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	5.42e-05	0.0038	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	5.32e-05	0.00374	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	5.23e-05	0.00367	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—CYP2C9—brain cancer	5.2e-05	0.00365	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—APC—brain cancer	5.15e-05	0.00362	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	5.13e-05	0.0036	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	5.06e-05	0.00355	CbGpPWpGaD
Hexobarbital—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	5.02e-05	0.00353	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	4.46e-05	0.00313	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	4.18e-05	0.00293	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—CYP2C9—brain cancer	4.05e-05	0.00284	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—RELA—brain cancer	4.03e-05	0.00283	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	4e-05	0.00281	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	3.93e-05	0.00276	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.91e-05	0.00274	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—CTNNB1—brain cancer	3.5e-05	0.00246	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.46e-05	0.00243	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.44e-05	0.00241	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	3.19e-05	0.00224	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.18e-05	0.00223	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.13e-05	0.0022	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.08e-05	0.00217	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—STAT3—brain cancer	3.05e-05	0.00214	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.002	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	2.82e-05	0.00198	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.8e-05	0.00197	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.53e-05	0.00178	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	2.5e-05	0.00176	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.46e-05	0.00173	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.42e-05	0.0017	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	2.41e-05	0.00169	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.17e-05	0.00152	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.06e-05	0.00145	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2e-05	0.0014	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	1.97e-05	0.00138	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	1.85e-05	0.0013	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.74e-05	0.00122	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	1.7e-05	0.00119	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	1.66e-05	0.00117	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	1.66e-05	0.00117	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.56e-05	0.00109	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYP2C9—brain cancer	1.54e-05	0.00108	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.46e-05	0.00102	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.33e-05	0.000935	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—BSG—brain cancer	1.31e-05	0.000921	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000809	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.14e-05	0.000799	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—IDH1—brain cancer	1.13e-05	0.000792	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—BSG—brain cancer	9.8e-06	0.000688	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.18e-06	0.000645	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ENO2—brain cancer	8.92e-06	0.000626	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYP2C9—brain cancer	8.89e-06	0.000624	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—IDH1—brain cancer	8.43e-06	0.000592	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—BSG—brain cancer	7.56e-06	0.000531	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYP2C9—brain cancer	6.93e-06	0.000486	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—BSG—brain cancer	6.9e-06	0.000484	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ENO2—brain cancer	6.66e-06	0.000468	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—IDH1—brain cancer	6.5e-06	0.000456	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—IDH1—brain cancer	5.93e-06	0.000416	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—BSG—brain cancer	5.89e-06	0.000414	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYP2C9—brain cancer	5.35e-06	0.000375	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.3e-06	0.000372	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ENO2—brain cancer	5.14e-06	0.000361	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—IDH1—brain cancer	5.07e-06	0.000356	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.83e-06	0.000339	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ENO2—brain cancer	4.69e-06	0.000329	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—BSG—brain cancer	4.55e-06	0.000319	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.13e-06	0.00029	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3CG—brain cancer	4.09e-06	0.000287	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ENO2—brain cancer	4.01e-06	0.000281	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—IDH1—brain cancer	3.91e-06	0.000274	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ENO2—brain cancer	3.09e-06	0.000217	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3CG—brain cancer	3.06e-06	0.000215	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3CG—brain cancer	2.36e-06	0.000166	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3CG—brain cancer	2.15e-06	0.000151	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3CG—brain cancer	1.84e-06	0.000129	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3CG—brain cancer	1.42e-06	9.95e-05	CbGpPWpGaD
